Milciclib

TargetMol
Product Code: TAR-T6081
Supplier: TargetMol
CodeSizePrice
TAR-T6081-1mg1mg£137.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6081-1mL1 mL * 10 mM (in DMSO)£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6081-5mg5mg£230.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6081-10mg10mg£330.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6081-25mg25mg£510.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6081-50mg50mg£703.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6081-100mg100mg£938.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
Milciclib (PHA-848125) is a potent, ATP-competitive CDK inhibitor for CDK2 with IC50 of 45 nM. It is >3-fold more selective for CDK2 than CDK1, 2, 4, 5, and 7. Phase 2.
CAS:
802539-81-7
Formula:
C25H32N8O
Molecular Weight:
460.586
Pathway:
Tyrosine Kinase/Adaptors; Autophagy; Cell Cycle/Checkpoint
Purity:
0.9973
SMILES:
CNC(=O)c1nn(C)c-2c1C(C)(C)Cc1cnc(Nc3ccc(cc3)N3CCN(C)CC3)nc-21
Target:
Trk receptor; CDK; Autophagy

References

Albanese C, et al. Mol Cancer Ther. 2010, 9(8), 2243-2254. Brasca MG, et al. J Med Chem. 2009, 52(16), 5152-5563. Degrassi A, et al. Mol Cancer Ther. 2010, 9(3), 673-681. Caporali S, et al. Pharmacol Res. 2010, 61(5), 437-448. Wu Z, Huang Z, Zhou X, et al.Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma.Genomics.2023: 110732.